
NAD+ is regenerated when NADH is oxidized back to NAD+. The mitochondrial respiratory chain performs this recycling inside mitochondria. Cytosolic NADH can be oxidized indirectly through the malate–aspartate shuttle, which connects its reducing power to mitochondrial respiration. Lactate dehydrogenase provides another cytosolic route by coupling NADH oxidation to the conversion of pyruvate into lactate; that reaction is distinct from respiratory-chain oxidation. These processes restore the oxidized form of an existing coenzyme rather than manufacture a new molecule.
Regeneration Is Redox Recycling, Not New NAD+
NAD+ and NADH are the oxidized and reduced forms of a redox couple involved in cellular metabolism. Their relative availability matters, not just the amount of NAD(H) present. Cellular NAD(H) pools are also compartmentalized, so a change in one location does not necessarily describe the state of the whole cell.[1]
During oxidation–reduction reactions, NAD+ participates in hydrogen transfer. Conversion between NAD+ and NADH allows the coenzyme to connect reactions that release reducing power with reactions that accept it.[2] Regeneration describes the return from NADH to NAD+: it restores the form needed by an NAD+-dependent reaction without increasing the number of coenzyme molecules.
NAD+ also participates in processes outside this redox cycle. Sirtuins, CD38 and poly(ADP-ribose) polymerases are examples of non-redox NAD+-dependent enzymes.[3] NAD+ consumption by these enzymes and NADH reoxidation are therefore different kinds of accounting. Reoxidizing NADH cannot, by itself, replace molecules lost through NAD+-consuming reactions. This is why regeneration and biosynthesis must be distinguished even though both affect the availability of NAD+.
Mitochondrial NADH: The Respiratory Chain Does the Oxidizing
The respiratory chain oxidizes mitochondrial NADH, returning it to NAD+. Evidence from acutely dissociated rat neocortical neurons and isolated mitochondria illustrates this connection: increased respiratory-chain NADH oxidation was accompanied by a higher NAD+/NADH ratio and enhanced mitochondrial respiration.[4]
The important relationship is between electron transfer and coenzyme recycling. NADH oxidation is not an additional supply pathway running beside respiration; it is part of the respiratory process. As NADH is oxidized, the same coenzyme becomes available again in its NAD+ form. A higher NAD+/NADH ratio can therefore reflect redistribution within an existing pool rather than an increase in the total amount of NAD(H).
In that neuronal experiment, ketones increased NADH oxidation and reduced mitochondrial reactive oxygen species production without changing glutathione levels.[4] The observation connects respiratory activity with redox state in a specific experimental model. It does not establish that the same intervention improves human health, nor does it make the NAD+/NADH ratio a stand-alone measure of clinical benefit.
Cytosolic NADH: The Malate–Aspartate Shuttle

Cytosolic NADH does not freely cross the mitochondrial inner membrane. The cytosolic and mitochondrial NAD(H) pools are not one freely mixing reservoir. A shuttle connects their redox reactions without requiring an NADH molecule to pass directly from the cytosol into the matrix.
The malate–aspartate shuttle provides a route for mitochondrial oxidation of cytosolic NADH. It is a major pathway for NADH oxidation in mammalian tissues, including liver and heart.[5] Describing it as a transfer of reducing equivalents preserves the essential distinction: reducing power is transferred between compartments, rather than cytosolic NADH simply entering mitochondria unchanged.
The shuttle is also linked to the driving force generated by respiration. Aspartate export from mitochondria depends on the respiratory chain’s proton-motive force: each aspartate exported is coupled to uptake of one glutamate and one proton. This coupling makes the shuttle effectively unidirectional toward oxidation of cytosolic NADH.[5]
That directionality helps explain how connected compartments can retain different redox states. The free NADH/NAD ratio is much higher in mitochondria than in the cytosol.[5] Connection through a shuttle does not mean that the two pools reach the same ratio. Consequently, a mitochondrial redox measurement cannot simply substitute for a cytosolic measurement when interpreting NAD+ availability.
Lactate Dehydrogenase: Cytosolic Regeneration That Cuts Both Ways

Lactate dehydrogenase links the pyruvate–lactate pair to the NAD+/NADH pair. In the pyruvate-to-lactate direction, NADH is oxidized and NAD+ is regenerated in the cytosol. This provides a route for recycling cytosolic NADH without sending its reducing equivalents into the mitochondrial respiratory chain.
The reverse direction matters equally. In cultured T cells exposed to low-glucose, high-lactate conditions, lactate dehydrogenase reduced NAD+ to NADH. The resulting redox state limited NAD+ availability for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and 3-phosphoglycerate dehydrogenase (PGDH), producing blocks at those reactions.[6]
Thus, saying that lactate dehydrogenase regenerates NAD+ is incomplete unless the reaction direction is specified. Pyruvate reduction regenerates NAD+; the opposite direction reduces NAD+ to NADH. The same enzyme can participate in either outcome, so its presence alone does not establish which way the coenzyme balance is moving.
The T-cell findings also explain why lactate is not a simple indicator that NAD+ recycling has stopped. Formation of lactate through pyruvate reduction can accompany NAD+ regeneration, whereas a lactate-rich environment can favor the opposite redox effect in the experimental conditions described above. Concentration and reaction direction are different pieces of information; one should not be treated as an automatic readout of the other.
Biosynthesis Makes NAD+; Regeneration Reoxidizes It
De novo synthesis builds NAD from amino acid precursors. In mouse kidney and cell research, PGC1α increased expression of enzymes involved in this pathway, while PGC1α deficiency or acute kidney injury attenuated it. The same study reported that nicotinamide, also called NAM, enhances NAD through the enzyme nicotinamide phosphoribosyltransferase, or NAMPT.[7]
These are two distinct biosynthetic routes: de novo synthesis from amino acids and NAMPT-mediated salvage using NAM. NAMPT was described as the rate-limiting enzyme in mammalian NAD+ biosynthesis in mouse and cell research that also linked NAMPT and NAD+ oscillations to the circadian clock.[8] Its role here concerns making NAD+, not respiratory-chain oxidation of NADH.
The distinction can be stated as two different questions. Biosynthesis asks how a cell produces NAD+ from precursors. Regeneration asks how NADH formed during metabolism becomes NAD+ again. Increasing precursor-based synthesis is therefore not the same biochemical event as increasing NADH oxidation. Neither the mouse kidney findings nor the clock experiments establish human benefits from changing either process.
Why Regeneration Matters for Glycolysis
GAPDH requires NAD+ to support its reaction in glycolysis. The cultured T-cell experiments showed the consequence of restricted availability: increased lactate led to a block at GAPDH and depletion of glycolytic intermediates downstream of that step.[6]
This connects coenzyme recycling to metabolic continuity. Having NAD(H) present is not sufficient if too much of the relevant pool is in the NADH form. NAD+-dependent reactions need the oxidized coenzyme, while the routes discussed above provide ways to restore it. Total pool size, oxidation state and cellular location therefore answer different questions about whether NAD+ is available where a reaction needs it.
The T-cell result is evidence from cell culture, while the respiratory-chain experiment used rat neurons and isolated mitochondria. The biosynthesis examples come from mouse and cell work. These models explain biochemical relationships, not human treatment outcomes. Human health benefits and the safety of NAD+ restoration remain unresolved questions in the review literature.[3]
For the title question, the essential answer is NADH reoxidation: directly through the mitochondrial respiratory chain, indirectly for cytosolic NADH through the malate–aspartate shuttle, or locally through the pyruvate-to-lactate reaction. Precursor-based synthesis addresses a different task—making the coenzyme rather than recycling its redox state.
Related research: 5-Amino-1MQ Mechanism of Action; What Is NAD +; What Is the NAD+/NADH Ratio?; NAD+.
*Research Use Only Disclaimer: This article is for laboratory research and analytical education. It is not a validated experimental protocol or medical or veterinary advice, and it does not provide instructions for administration to humans or animals.*
References
- NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
- NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
- NAD+ metabolism and its roles in cellular processes during ageing
- Ketones inhibit mitochondrial production of reactive oxygen species following glutamate excitotoxicity by increasing NADH oxidation
- The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway
- Lactate Limits T Cell Proliferation via the NAD(H) Redox State
- PGC1alpha drives NAD biosynthesis linking oxidative metabolism to renal protection
- Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis